Cells with IFITM5 mutation get caught in a loop leading to osteogenesis imperfecta type V
These findings not only inform on the mechanism of OI type V, they also facilitate the development of future therapies for this condition.
Read More
Targeting TGF-β for treatment of osteogenesis imperfecta
A monoclonal antibody therapy that neutralizes TGF-β produced promising results in a Phase 1 clinical trial.
Read More
Young author raises brittle bone disease awareness, receives prestigious award
When she was nine years old, Andersson Dyke, a cat lover, began imagining an idea for a story; the journey of an abandoned lion cub
Read More